"Global Demand Outlook for Executive Summary HER2 Positive Breast Cancer Treatment Market Size and Share
Data Bridge Market Research analyses a growth rate in the global HER2 positive breast cancer treatment market in the forecast period 2022-2029. The expected CAGR of global HER2 positive breast cancer treatment market is tend to be around 1.50% in the mentioned forecast...
"In-Depth Study on Executive Summary Anti-Metabolite Drugs Market Size and Share
Anti-metabolite drugs market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.60% in the above mentioned forecast period.
The Anti-Metabolite Drugs Market report contains market insights and analysis...
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...
According to a new report from Intel Market Research, the global Computed Tomography (CT) Simulators market was valued at USD 1.02 billion in 2025 and is projected to reach USD 1.65 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025–2034). This growth is propelled by the rising global cancer burden, technological advancements in image-guided radiotherapy (IGRT),...
According to a new report from Intel Market Research, the global Durvalumab Market was valued at USD 1.85 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to USD 4.76 billion by 2034, exhibiting a robust CAGR of 10.6% during the forecast period. Growth is driven by increasing cancer prevalence, advancements in immuno-oncology research, and rising investments in targeted...
According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
According to a new report from Intel Market Research, the global Nimustine Hydrochloride market was valued at USD 78.5 million in 2024 and is projected to grow from USD 82.4 million in 2025 to USD 112.9 million by 2034, exhibiting a robust CAGR of 3.6% during the forecast period. Market growth is driven by increasing cancer prevalence, particularly in neurology and hematology applications,...
According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
According to a new report from Intel Market Research, the global Superficial X-Ray Therapy System market was valued at USD 312.5 million in 2025 and is projected to reach USD 472.8 million by 2034, growing at a CAGR of 4.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-melanoma skin cancers, increasing patient preference for...
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek